Summary: Beckman Coulter adds Neurodegenerative research

Why It Matters: This shows Beckman Coulter is focusing on new disease areas. This could mean new products or services.

What Changed:

• The main headline changed from "Advancing Your Clinical Capabilities" to "Powering the Moments that Matter at NHLS Sebokeng Laboratory Gauteng, South Africa".
• A section titled "Revealing Greater Insights" was removed.
• New sections were added: "Together, We're Reimagining Diagnostics", "Add More Advantage to Your Workflows", and "Empowering Neurodegenerative Disease Research".
• The "Empowering Neurodegenerative Disease Research" section highlights GFAP, NfL, APOE ε4, and pTau-217 assays.
• The "Explore Our Products" section now has "Empty heading" above the DxC 500 AU and DxI 9000 products.
• A cookie consent message was added at the very end of the content.